Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01947608
Title Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST